| [1] | 黄肖桦. 巴马紧盯关键环节强化监督推动春耕备耕“齐步走”[N/OL]. 河池日报, 2021-03-18(2). http://www.gxhczx.gov.cn/html/news-view-37219.html. |
| [2] | ZHAO H, SUN C, STEWART R J, et al. Cement proteins of the tube-building polychaete Phragmatopoma californica[J]. Journal of Biological Chemistry, 2005, 280(52): 42938 − 42944. doi: 10.1074/jbc.M508457200 |
| [3] | ABBOTT A. Levodopa: the story so far[J]. Nature, 2010, 466(7310): 6 − 7. doi: 10.1038/466S6a |
| [4] | ZHU W, CHUAH Y J, WANG D A. Bioadhesives for internal medical applications: A review[J]. Acta Biomaterialia, 2018, 74: 1 − 16. doi: 10.1016/j.actbio.2018.04.034 |
| [5] | SAHA A, NIR S, RECHES M. Amphiphilic peptide with dual functionality resists biofouling[J]. Langmuir, 2020, 36(15): 4201 − 4206. doi: 10.1021/acs.langmuir.9b03997 |
| [6] | BLACK, K C L, LIU Z, MESSERSMITH P B. Spontaneous formation of polymer-stabilized noble metal nanoparticles using catechol polymers[J]. Polymer Preprints (American Chemical Society, Division of Polymer Chemistry), 2010, 51(2): 52 − 53. |
| [7] | HEBEL M, RIEGGER A, ZEGOTA M M, et al. Sequence programming with dynamic boronic acid/catechol binary codes[J]. Journal of the American Chemical Society, 2019, 141(36): 14026 − 14031. doi: 10.1021/jacs.9b03107 |
| [8] | MOROKUMA K, LIJIMA D, OKUNO M, et al. Liquid compositions comprising a levodopa amino acid conjugate and uses thereof. WO2021044420[P]. 2021-03-01. |
| [9] | LIU Z, ZHANG X Y, HU B H, et al. Method for synthesizing DOPA-containing oligopeptide, and its application in preparing prodrug for treating Parkinson disease. WO2020169012[P]. 2020-08-27. |
| [10] | LIU Z, HU B H, MESSERSMITH P B. Convenient synthesis of acetonide protected 3, 4-dihydroxyphenylalanine (DOPA) for Fmoc solid-phase peptide synthesis[J]. Tetrahedron Lett, 2008, 49(38): 5519 − 5521. doi: 10.1016/j.tetlet.2008.07.052 |
| [11] | WUTS P G M, GREENE T W. Greene's protective groups in organic synthesis[M]. 5ed. Hoboken: John Wiley & Sons, Inc, 2014. |
| [12] | YAMAMOTO Y. New DOPA derivative and its production. JPH05112576 [P]. 1993-05-07. |
| [13] | MESSERSMITH P B, HU B H, LIU Z. Method of synthesizing acetonide-protected catechol-containing compounds and intermediates produced therein. US20100087622[P]. 2019-01-31. |
| [14] | PETER W, ROGER M S. Thin-Layer Chromatography: A modern practical approach[M]. London: Royal Society of Chemistry, 2009: 134−153. |
| [15] | 陈瑜, 李如雯, 谢树英, 等. 新型18 F标记的多巴胺正电子发射显影剂前体的合成[J]. 化学试剂, 2022, 44(8): 7 − 16. |
| [16] | SEVER M J, WILKER J J. Synthesis of peptides containing DOPA (3, 4-dihydroxyphenylalanine)[J]. Tetrahedron, 2001, 57(29): 6139 − 6146. doi: 10.1016/S0040-4020(01)00601-9 |
| [17] | SEVER M J, WILKER J J. Absorption spectroscopy and binding constants for first-row transition metal complexes of a DOPA-containing peptide[J]. Dalton Transactions, 2006, 14(6): 813 − 822. |
| [18] | WEISSER J T, NILGES M J, SEVER M J, et al. EPR investigation and spectral simulations of iron-catecholate complexes and iron peptide models of marine adhesive cross-links[J]. Inorganic Chemistry, 2006, 45(19): 7736 − 7747. doi: 10.1021/ic060685p |
| [19] | PERSSON I. Ferric chloride complexes in aqueous solution: An EXAFS study[J]. Journal of Solution Chemistry, 2018, 47(5): 797 − 805. doi: 10.1007/s10953-018-0756-6 |
| [20] | SEVER M J, WILKER J J. Visible absorption spectra of metal–catecholate and metal-tironate complexes[J]. Dalton Transactions, 2004(7): 1061 − 1072. doi: 10.1039/B315811J |
| [21] | SMITH R M, MARTELL A E. Critical Stability Constants[M]. Boston,MA: Springer US, 1989. |
| [22] | AVDEEF A, SOFEN S R, BREGANTE T L, et al. Coordination chemistry of microbial iron transport compounds. 9. Stability constants for catechol models of enterobactin[J]. Journal of the American Chemical Society, 1978, 100(17): 5362 − 5370. doi: 10.1021/ja00485a018 |